2009 has seen an increased spotlight put on the potential of stem cell research. Adult stem cells, such as those derived from adipose tissue, are free of ethical issues and are not considered controversial. Progress in this area of research has advanced rapidly over the past decade.
Cytori’s cell-based technology is sold to investigators worldwide to fulfill demand for adult stem and regenerative cell research. The technology’s real time processing capabilities enable investigators to apply these cells across an array of applications. Investigators choose to study outcomes to better understand the benefit of these cells in their own independently sponsored preclinical, in-vitro, or regulated studies. We are aware of independent studies for cell-enriched breast augmentation, Crohn’s disease, stress urinary incontinence, and liver insufficiency that are utilizing Cytori’s technology.